August 21, 2013

LifeScan announced that the U.S. District Court for the Eastern District of New York entered a permanent injunction against Pakistani distributors of counterfeit OneTouch Test Strips and awarded the company damages of $3.3 million.

March 25, 2013

LifeScan initiated a voluntary recall and replacement for all of its OneTouch VerioIQ blood-glucose meters in the United States, effective immediately.

October 19, 2012

Blood glucose monitoring is associated with reduced A1C levels and greater adherence to medication in Type 2 diabetes patients who do not take insulin, according to a study published in the September issue of Diabetes Technology & Therapeutics.

June 1, 2011

LifeScan announced a major settlement regarding counterfeit packaged LifeScan blood-glucose monitoring test strips sold by Aristides Spanellis.